The METiS platform (AiTEM) combines state-of-the-art AI data-driven algorithms, mechanism- driven quantum mechanics and molecular dynamics simulations to calculate Active Pharmaceutical Ingredient (API) properties, elucidate API-target and API-excipient interactions, and predict chemical, physical and pharmacokinetic properties of small molecule and nucleic acid therapeutics in specific microenvironments. This enables efficient lead optimization, candidate selection and formulation design. Founded by a team of MIT researchers, serial entrepreneurs and biotech industry veterans, METiS develops and in-licenses novel assets with high therapeutic potential that could benefit from its data-driven platform.
Company Details
- Employees
- 30
- Address
- Cambridge, Ma 02142, Us
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.metistx.com
- HQ
- Cambridge, MA
Metis Therapeutics Questions
Metis Therapeutics's website is http://www.metistx.com
Metis Therapeutics's LinkedIn profile is https://www.linkedin.com/company/metistx
Metis Therapeutics has
30 employees.
View email and phone details for 30
employees at Metis Therapeutics.
Metis Therapeutics's industry is
Pharmaceutical Manufacturing
Metis Therapeutics's top competitors are
Integrated Nanotherapeutics Inc.,
Neurox1 Inc.,
Sisaf Ltd,
Nanite,
Notch Therapeutics,
Nanovation Therapeutics™,
Metis Pharmaceuticals,
杭州剂泰医药,
Hopewell Therapeutics, Inc.,
Abdera Therapeutics.
Metis Therapeutics's categories are Pharmaceutical Manufacturing
